HCV-specific production of IL-10 and IFN-gamma-inducible protein-10 (IP-10) levels predict treatment response to pegylated interferon and ribavirin in children with chronic hepatitis C infection

被引：0
|
作者：
Carey, Ivana [1 ]
Mytilinaiou, Maria [1 ]
Hussain, Munther [1 ]
Bansal, Sanjay [1 ]
Subramaniam, Pushpa [1 ]
Horner, Mary [1 ]
Longhi, Maria Serena [1 ]
Meda, Francesca [1 ]
Mieli-Vergani, Giorgina [1 ]
Vergani, Diego [1 ]
机构：
[1] Kings Coll London, Sch Med, Univ London Kings Coll Hosp, Inst Liver Studies, London WC2R 2LS, England
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
101
引用
收藏
页码：279A / 279A
页数：1
相关论文
共 50 条
  • [11] LOW PRE-TREATMENT NUMBERS OF CD4+/PD-1+LYMPHOCYTES AND LOW HCV-SPECIFIC IL-10 PRODUCTION DURING THERAPY WITH PEGYLATED-INTERFERON plus RIBAVIRIN PREDICT RESPONSE IN CHILDREN WITH CHRONIC HEPATITIS C
    Carey, I.
    Bansal, S.
    Mendes, A.
    Subramaniam, P.
    Cebecauerova, D.
    Vergani, D.
    Mieli-Vergani, G.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E17 - E17
  • [12] LOW PRE-TREATMENT NUMBERS OF CD4+/PD1+LYMPHOCYTES AND LOW HCV-SPECIFIC IL-10 PRODUCTION DURING THERAPY WITH PEGYLATED-INTERFERON plus RIBAVIRIN PREDICT RESPONSE IN CHILDREN WITH CHRONIC HEPATITIS C
    Carey, I.
    Mendes, A.
    Cebecauerova, D.
    Bansal, S.
    Subramaniam, P.
    Tizzard, S.
    Mieli-Vergani, G.
    Vergani, D.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S266 - S266
  • [13] INTERFERON-GAMMA-INDUCIBLE PROTEIN-10 (IP-10), A MEMBER OF THE C-X-C CHEMOKINE FAMILY, IS AN INHIBITOR OF ANGIOGENESIS
    STRIETER, RM
    KUNKEL, SL
    ARENBERG, DA
    BURDICK, MD
    POLVERINI, PJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (01) : 51 - 57
  • [14] The clinical significance of interferon inducible protein-10 in chronic hepatitis C patients with genotype I undergoing pegylated interferon and ribavirin therapy
    Kim, Chung Ho
    Kim, Ji Hoon
    Jong, Young Kul
    Kim, Jeong Han
    Choi, Jong Hwan
    Hong, Seong Kweon
    Ju, Moon Kyung
    Lee, Beom Jae
    Yim, Hyung Joon
    Yeon, Jong Eun
    Park, Jong-Jae
    Kim, Jae Seon
    Bak, Young Tae
    Byun, Kwan Soo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A42 - A42
  • [15] Association of pretreatment serum interferon-gamma inducible protein 10 (IP-10) levels with virological response to lamivudine monotherapy and lamivudine interferon sequential treatment in chronic hepatitis B
    Nagaoka, Shinya
    Yatsuhashi, Hiroshi
    Nakao, Rumiko
    Fukuda, Mika
    Hashimoto, Satoru
    Nishikawa, Akiko
    Hai, Naruhiro
    Tateyama, Masakuni
    Ozawa, Eisuke
    Taura, Naota
    Abiru, Seigo
    Yano, Koji
    Komori, Atsumasa
    Migita, Kiyoshi
    Fujioka, Hikaru
    Ishibashi, Hiromi
    [J]. HEPATOLOGY, 2007, 46 (04) : 670A - 671A
  • [16] PRETREATMENT SERUM INTERFERON-GAMMA-INDUCIBLE PROTEIN (IP-10) LEVELS PREDICT THE RESPONSE TO TREATMENT IN EGYPTIAN PATIENTS INFECTED WITH HCV GENOTYPE 4A
    Eldars, W. M.
    El-Bendary, M.
    Hawas, S.
    El-Nady, G.
    Ali, M.
    Zalata, K.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S168 - S168
  • [17] Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C
    Matsuura, Kentaro
    Watanabe, Tsunamasa
    Iijima, Sayuki
    Murakami, Shuko
    Fujiwara, Kei
    Orito, Etsuro
    Iio, Etsuko
    Endo, Mio
    Kusakabe, Atsunori
    Shinkai, Noboru
    Miyaki, Tomokatsu
    Nojiri, Shunsuke
    Joh, Takashi
    Tanaka, Yasuhito
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (12) : 1208 - 1216
  • [18] Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection
    Mascia, Claudia
    Lichtner, Miriam
    Zuccala, Paola
    Vita, Serena
    Tieghi, Tiziana
    Marocco, Raffaella
    Savinelli, Stefano
    Rossi, Raffaella
    Lannetta, Marco
    Cannpagna, Michela
    Schiavone, Francesco
    Mengoni, Fabio
    Russo, Gianluca
    Mastroianni, Claudio Maria
    Vullo, Vincenzo
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (06) : 644 - 655
  • [19] Plasma Interferon-Gamma-Inducible Protein-10 Levels Are Associated with Early, but Not Sustained Virological Response during Treatment of Acute or Early Chronic HCV Infection
    Feld, Jordan J.
    Grebely, Jason
    Matthews, Gail V.
    Applegate, Tanya
    Hellard, Margaret
    Sherker, Alana
    Cherepanov, Vera
    Petoumenos, Kathy
    Yeung, Barbara
    Kaldor, John M.
    Lloyd, Andrew R.
    Dore, Gregory J.
    [J]. PLOS ONE, 2013, 8 (11):
  • [20] Pretreatment levels of interferon-gamma inducible protein 10 kda (IP-10) predict viral kinetic response and outcome in difficult-to-treat patients with chronic hepatitis C virus genotype 1 infection receiving peginterferon alfa-2a and ribavirin
    Lagging, M
    Romero, A
    Westin, J
    Pawlotsky, JM
    Zeuzem, S
    Negro, F
    Schalm, SW
    Haagmans, BL
    Ferrari, C
    Neumann, AU
    Hellstrand, K
    [J]. HEPATOLOGY, 2005, 42 (04) : 649A - 649A
12345